Inflammatory Bowel Disease Research

The Mater Inflammatory Bowel Disease Research Group’s collective emphasis on clinical translational research using a multi-disciplinary, highly collaborative, patient focused approach enables the integration of commercial and academic research with exceptional patient care.

The Research Group is focused on advancing innovative, preventative and therapeutic approaches to treating gut inflammation.

The Group's vision is to revolutionise clinical practice by leading in clinical and translational research at the intersection of the microbiome, inflammation and gut health.